Δρ Άρτεμις Δουλγεράκη 

Δημοσιεύσεις

• Markopoulou,P.; Doulgeraki, A.; Koutroumpa, A.; Polyzois, G.; Athanasopoulou, H.; Kanaka-Gantenbein, C.; Siahanidou, T. The Long-Term Impact of Preterm Birth on Metabolic Bone Profile and Bone Mineral Density in Childhood. Metabolites 2025,15, 463
   
• Gravia,A.P.; Vastardis, H.; Tsolakis, A.I.; Doulgeraki,A. Orthodontics in Pediatric Οsteoporosis:A Narrative Literature Review. Children 2025,12, 691
   
• MariaNikita, Artemis Doulgeraki, Margarita Baka, Charalampos Tsentidis, George Polyzois, Helen Athanasopoulou, Dimitrios Doganis, Theodora Anastasiou, Varvara Douna & Lydia Kossiva: Bone mineral status at diagnosis οf childrenwith hematologic malignancy, PedHematolOncol, Αpr 2025;DOI:10.1080/08880018.2025.2487435
   
• SakkaS, Georgakopoulou D, Doulgeraki A etal. Burosumab treatment of a child withMcCune Albright Syndrome/polyostotic fibrous dysplasia- Challenges andbenefits. JBMR Plus, 2025,9, ziaf042
   
• Δουλγεράκη Α. «Αντιμετώπιση της οστεοπόρωσης σε παιδιά κι εφήβους». Οστούν, Νοέμβριος 2024
   

• Artemis Doulgeraki, Fan Wang, Anastasia Skouma, Eleana
  Petropoulou, SymeonTournis, Alice Costantini, Outi Mäkitie.
  Co-occurrenceof two rare diseases: a child with phenylketonuria and WNT1osteoporosis. Horm Res Paediatr . 2024 Nov 27:1-17.  doi:
  10.1159/000541378, οnline ahead of print.
   
• EleniStatha, George Paltoglou, Artemis Doulgeraki et al. A toddler withsevere vitamin D dependent rickets type 1A (VDDR1A), «hungry bones» and astormy RSV infection: presentation and therapeutic challenges. Hormones(Athens) 2024 Dec;23(4):835-839. doi:10.1007/s42000-024-00579-2
  
  
• Doulgeraki A, Bani-Odeh L, Tramma D et al. Severe hypophosphataemia can be an early sign ofosteopetrorickets: a case report..J Pediatr Endocrinol Metab. 2023 May 5;36(7):712-715
   
• Tsentidis C, Gourgiotis D, Kossiva L, Marmarinos A, Doulgeraki A, Karavanaki K. Higher Adiponectin Levels in Childrenand Adolescents with T1D Probably Contribute to the Osteopenic Phenotypethrough the RANKL/OPG System Activation. Endocrines 2023, 4, 709–719
  
  
• Doulgeraki A, Laurent MR. Editorial: Rickets and osteomalacia, from genes to nutrition. Front Endocrinol (Lausanne). 2023; Jan 19; 14:1141888. doi: 10.3389/fendo.2023.1141888
  
  
• Tournis S, Yavropoulou MP, Polyzos SA, Doulgeraki A.  Hypophosphatasia..J Clin Med. 2021Dec 1;10(23):5676
  
  
• Koutroumpa A, Kanaka Gantenbein C, Mantzou A, DoulgerakiA, et al. CirculatingIrisin Levels in Preadolescents and Adolescents Born Preterm. Horm Res  Paediatr. 2021;94(11-12):416-425
   
• Pergantou H, Papakonstantinou O, Xafaki P, Athanasopoulou H, Balanika A, Kattamis A, Chroussos G, Platokouki H, Doulgeraki A. Uncoupling
  of bone turnover may compromise skeletal health of young patients with
  haemophilia A. J Clin Densitom 2022;25(1):89-96
  
  
• Agouropoulos A,Gatzogianni M, Doulgeraki A et al. Oral health status of children with Osteogenesis Imperfecta, submitted for publication
  
  
• Δουλγεράκη Άρτεμις. «Κατευθυντήριες οδηγίεςσκελετικής υγείας στη μυική δυστροφία Duchenne”, Οστούν 2022; 29(4): 161
  
  
• Chronic Hemolysis May Adversely Affect Skeletal Health. ACross-Sectional Study of a Pediatric Population. Doulgeraki A, Fragodimitri C, Athanasopoulou H,Drakaki K, Karabatsos F, Schiza V, Yousef J, Monopolis I, Chatziliami A. Hemoglobin2021 Jan;45(1):30-36. doi: 10.1080/03630269.2021.1879129.Epub 2021 Feb 8.PMID: 33557624
  
  
• Novel Hemizygous Missense Variant of Spermine Synthase (SMS) GeneCauses Snyder-Robinson Syndrome in a Four-Year-Old Boy.Mouskou S, Katerelos A, Doulgeraki A,Leka-Emiri S, Manolakos E, Papoulidis I, Ververi A, Vartzelis G, Korona A,Mastroyanni S, Voudris K. Mol Syndromol 2021 Jun;12(3):194-199. doi: 10.1159/000514122.Epub 2021 Apr 19.PMID: 3417743
  
  
• Denosumab for the treatment of primary pediatric osteoporosis. Anastasilakis AD, MakrasP, DoulgerakiA, Polyzos SA, Guarnieri V, Papapoulos SE. Osteoporos Int 2021 May 13. doi: 10.1007/s00198-021-06002-5. Onlineahead of print.PMID: 33987688
  
  
• Papadopoulou A, Bountouvi E, Sideri V,Moutsatsou P, Skarakis NS, Doulgeraki A, Karachaliou FE. Bone 2021 May;146:115904. doi: 10.1016/j.bone.2021.115904. Epub 2021 Feb27.PMID: 33647526
  
  
• Uncoupling of Bone Turnover may Compromise Skeletal Health ofYoung Patients With Haemophilia A. Pergantou H, Papakonstantinou O, Xafaki P, AthanasopoulouH, Balanika A, Kattamis A, Doulgeraki A. J ClinDensitom 2021 Aug 4:S1094-6950(21)00068-8. doi:10.1016/j.jocd.2021.07.011. Online ahead of print.PMID: 34384686
  
  
• Parietal aplasia and hypophosphatasia in achild harboring a novelmutation in RUNX2 and a likely pathogenic variant in TNSALP. Papadopoulou A, Bountouvi E, Sideri V,Moutsatsou P, Skarakis NS, Doulgeraki A, Karachaliou FE. Bone 2021 May;146:115904. doi: 10.1016/j.bone.2021.115904. Epub 2021 Feb 27.PMID: 33647526
  
  
• Kalogerakou M, LambrouG, DoulgerakiA et al. Is basic bone profile affected in phenyloketonuria and hyperphenylalaninemia? The experience of the greek reference center.
  ActaOrthopedica Traumatologica Hellenica 2020; 70(3): 76-97
  
  
• Δουλγεράκη Άρτεμις. Ατελής οστεογένεση:Νεότερα δεδομένα. Οστούν, 2020
  
  
• Papadopoulou A, Bountouvi E, Sideri V,Moutsatsou P, Skarakis NS, Doulgeraki A, Karachaliou
  FE.Parietal aplasiaand hypophosphatasia in a child harboring a novel
  mutation in RUNX2 and avariant of unknown clinical significance in
  TNSALP. Submitted for publication,2020
  
  
• Mouskou S, Katerelos A, Manolakos E,Papoulidis I, Leka-Emiri S, Doulgeraki A et al. Novel hemizygous missensevariant of spermine synthase (SMS) gene causes Snyder-Robinson Syndrome in afour year-old boy. Submitted for publication, 2020
  
  
• Doulgeraki A et al. Chronic hemolysis may adversely affect skeletalhealth. A cross-sectional study of a pediatric population. Submitted forpublication, 2020
  
  
• Pergantou H, Papakonstantinou O, Xafaki P,Athanasopoulou H, Balanika A, Kattamis A, Chroussos G, Platokouki H, Doulgeraki Uncouplingof bone turnover may compromise skeletal health of young patients withhaemophilia A. Submitted for publication, 2020
  
  
• Kapogiannis C, DoulgerakiA et al. “Bone mineral density and skeletal manifestations in patients with Sotossyndrome: a cross sectional study”. Submitted for publication, 2020
  
  
• Doulgeraki A, Botsa
  E, Lourida Aet al. Bone health ispreserved in well-nourished patients
  with perinatally-acquired HIV. Experiencefrom a reference centre. Submitted for publication, 2020
  
  
• Bacopoulou F, ApostolakiD, DoulgerakiA et al. Serum spexin is correlated with lipoprotein(a) and androgens in femaleadolescents. J Clin Med. 2019 Dec 2;8(12):2103
  
  
• Book chapter:”Role of hormones in bone regulation andregeneration”, Artemis Doulgeraki, EugeniaLabropoulou, Christina Kanaka-Gantenbein. In: “Bone regeneration”, ProfHiranmoy DAS, University of Texas, USA, 2018
  
  
• Costantini A, Krallis PΝ, Kämpe A, KaravitakisEM, Taylan F, Mäkitie O, Doulgeraki A novel frameshift deletion in PLS3 causing severe primaryosteoporosis. JHum Genet. 2018 Aug;63(8):923-926
  
  
• Costantini A, Tournis S, Kämpe A, Ul Ain N,Taylan F, DoulgerakiA, Mäkitie O. Autosomal RecessiveOsteogenesis Imperfecta Caused by a Novel Homozygous COL1A2 Mutation. Calcif TissueInt. 2018 Sep;103(3):353-358
  
  
• Sarantis M, Kollia P, Samara S, AthanasopoulouH, Gyftodimou Y, Lianou D, Mpourazani E, DoulgerakiA. A new COL1A1 mutation in a Greek patient withosteogenesis imperfecta:
  response to a low-dose protocol of zoledronic acid andtwo-year
  follow-up. JRPMS 2018 Sep; 2(3), 75-80
  
  
• Arditi J, Thomaidis L, Frysira H, DoulgerakiA, Chrousos
  G, Kanaka-Gantenbein C. Long-term follow up ofa child with Klinefelter
  syndrome and achondroplasia from infancy to 16years. JPed Endocrinol Metab, 2017 Jul 26;30(7):797-803
  
  
• Doulgeraki A, Petrocheilou A,Petrocheilou G, Chrousos G et al. Body composition and lung function in children with cysticfibrosis and meconium ileus. Eur J Pediatr. 2017 Jun;176(6):737-743
  
  
• Doulgeraki AE, Manousakis EM, Papadopoulos NG. Bone health assessment of food allergic children on restrictivediets: a practical guide. JPediatr Endocrinol Metab. 2017 Feb 1;30(2):133-139
  
  
• van Erven B, Welling L, van Calcar SC, Doulgeraki A,Eyskens F, Gribben J, Treacy EP, Vos R, Waisbren SE, Rubio-Gozalbo ME, Bosch AM. Bone Health in Classic Galactosemia: Systematic Review andMeta-Analysis. JIMDRep. 2016 Dec 20. [Epub ahead of print]
  
  
• Tsentidis C, DoulgerakiA et al. Increased levels of Dickkopf-1 are indicative of Wnt/β-catenindownregulation and lower osteoblast signaling in children and adolescents withtype 1 diabetes mellitus, contributing to lower bone mineral density. Osteoporos Int 2017 Mar;28(3):945-953
  
  
• Papamerkouriou Y, Doulgeraki A et al. Osteogenesis imperfecta due to a possible new COL1A2 mutation; theimportance of phenotyping and diagnostic challenges. JNMI 2016,1; 16(2):168-171.
  
  
• Doulgeraki A, Athanasopoulou H et al. Body composition of patients with Duchennemuscular dystrophy; the Greek experience. Acta Neurol Belg 2016, 116 (4):565-572.
  
  
• Tsentidis C, DoulgerakiA et al. Higher levels of s-RANKL and osteoprotegerin in children andadolescents with type 1 diabetes mellitus may indicate increased osteoclastsignaling and predisposition to lower bone mass: a multivariate cross-sectionalanalysis. OsteoporosInt. 2016, 27(4): 1631-43.
  
  
• Tsentidis C, Doulgeraki A et al. Sclerostin distribution in children
  andadolescents with type 1 diabetes mellitus and correlation with bone
  metabolismand bone mineral density. Pediatr Diabetes 2016, 17(4):
  289-99.
  
  
• Rozis K, Pallis D, DoulgerakiA. Causes of secondary osteoporosis during childhood andadolescence. “Skeletiki Hygeia” 2016, 15(4), 137-148 (inGreek)
  
  
• Doulgeraki A. Bone mineral density assessment for the diagnostic work-upof paediatric osteoporosis. Ann Clin Ped Univ Atheniensis special edition 2016,
  
  
• Long-term follow-up of a child with Klinefelter syndrome andachondroplasia from infancy to 16 years. Arditi JD, Thomaidis L, Frysira H, Doulgeraki A,Chrousos GP, Kanaka-Gantenbein C.J Pediatr Endocrinol Metab. 2017 Jul26;30(7):797-803. doi: 10.1515/jpem-2016-0362. PMID: 28672740 147-157 (inGreek)
  
  
• Vlachopapadopoulou E, Doulgeraki A, Tsitsika A. Refeeding, menses resumption and improvement of bone density of adolescent girls with anorexia nervosa. Paidiatriki 2015,78(3): 334-344 (in Greek)
  
  
• Body composition of patients with Duchenne muscular dystrophy: the Greek experience.Doulgeraki AE, AthanasopoulouHI,
  Katsalouli MS, Petrocheilou GM, Paspati IN, MonopolisIK.Acta Neurol
  Belg. 2016 Dec;116(4):565-572. doi: 10.1007/s13760-015-0582-1.Epub 2015
  Dec 17.PMID: 26680652
  
  
• Doulgeraki A, Skarpalezou A etal. Body composition profile of young patients with phenylketonuria and mild hyperphenylalaninemia. Int J Endocrinol Metab. 2014 Jul 1; 12(3):e16061. doi:10.5812/ijem.16061.
  
  
• Papadopoulou A, BountouviE, Gole E, Doulgeraki A, et al. Identification
  of a novel nonsense mutation in the ligand-bindingdomain of the vitamin
  D receptor gene and clinical description of two greekpatients with
  hereditary vitamin D-resistant rickets and alopecia. Horm Res Paediatr. 2014, 82(3):206-12
  
  
• Doulgeraki A, Monopolis I et al: Body composition in young patients with galactose metabolicdisorders: a preliminary report. J Pediatr Endocrinol Metab. 2014, Jan 1;27(1-2):81-6.
  
  
• Doulgeraki A, Athanasopoulou H, et al. Non-ambulatory teenagers with DuchenneMuscular Dystrophy: bone geometry, density and metabolism. Paediatriki (inGreek), 2014, 25, 70-74.
  
  
• Athanasopoulou H, DoulgerakiA: The importance of Selenium in Paediatrics. TraceElements and Electrolytes, 2013, 30 (3): 100-104
  
  
• Doulgeraki A, Athanasopoulou H et al: Bone health evaluation of children and adolescents with homozygousβ-thalassemia: implications for practice. J Pediatr Hematol Oncol. 2012, Jul; 34(5):344-8.
  
  
• Doulgeraki A., Valari M.: “Parental attitudes towards head lice infestation in Greece”. Int J Dermatol,  2011, Jun;50(6):689-92             
  
  
• Doulgeraki A., Kotsonis K et al: “An interesting case of febrileneutropaenia”. Clinical Pediatrics, (Phila), 2007, 46(3),266-7.
  
  
• Doulgeraki A., Tsakiris S. et al: “Effects of L-Phenylalanine on Acetylcholinesterase and Na+,K+-ATPase activities insuckling rat frontal cortex, hippocampus and hypothalamus.” Z. Naturforsch. 2002,57c, 182-188.
  
  
• Schulpis K., Doulgeraki A.,and Tsakiris S.: “Changes of the brain synapses during aging. New aspects.”Z. Naturforsch. 2001, 56c, 921-929.
  
  
• Schulpis K., Doulgeraki A., and Tsakiris S. :“Factors affecting neurogenesis during neonatal period. Areview. ”Paediatriki, 2001, 64, 49-54 (in Greek)
  
  
• Doulgeraki A., Tsakiris S., et al:“In vitro effect of the noradrenalineneurotoxin DSP-4 and L-Phenylalanine on rat brain Na+,K+-ATPaseactivity.” Res.Commun.Biol.Psychol.Psychiatry, 1999, 24, 59-62.